Search Result "amidolytic activities"
Synthesis and Activity of N-Sulfonylamides of Tripeptides as Potential Urokinase Inhibitors
Journal: Protein & Peptide Letters
Volume: 17 Issue: 1 Year: 2010 Page: 1300-1304
Author(s): Agnieszka Markowska, Irena Bruzgo, Wojciech Miltyk, Krystyna Midura-Nowaczek
Structural Findings and Molecular Modeling Approach of a TFPI-Like Inhibitor
Journal: Protein & Peptide Letters
Volume: 21 Issue: 5 Year: 2014 Page: 452-457
Author(s): Kerly Fernanda Mesquita Pasqualoto,Andrea Balan,Sandra Alves Barreto,Simone Michaela Simons,Ana Marisa Chudzinski-Tavassi
Snake Venom Prothrombin Activators Similar to Blood Coagulation Factor Xa
Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 4 Issue: 4 Year: 2004 Page: 397-416
Author(s): Jeremiah S. Joseph, R. Manjunatha Kini
Enzymes with Phosphotriesterase and Lactonase Activities in Archaea
Journal: Current Chemical Biology
Volume: 2 Issue: 3 Year: 2008 Page: 237-248
Author(s): Luigia Merone, Luigi Mandrich, Mose Rossi, Giuseppe Manco
Structure, Function, and Activation of Coagulation Factor VII
Journal: Current Protein & Peptide Science
Volume: 3 Issue: 3 Year: 2002 Page: 287-299
Author(s): Charles Eigenbrot
Fibrin Binding and the Regulation of Plasminogen Activators during Thrombolytic Therapy
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 6 Issue: 3 Year: 2008 Page: 212-223
Author(s): C. Longstaff, S. Williams, C. Thelwell
Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 27 Year: 2012 Page: 4215-4222
Author(s): Patricia D. Williams,Berislav V. Zlokovic,John H. Griffin,Kent E. Pryor,Thomas P. Davis
DNA Aptamers for Human Thrombin with High Anticoagulant Activity Demonstrate Target- and Species-Specificity
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 30 Year: 2012 Page: 5232-5237
Author(s): E. Zavyalova,A. Golovin,T. Timoshenko,A. Babiy,G. Pavlova,A. Kopylov
Plasminogen Activator Inhibitor with Very Long Half-life (VLHL PAI-1) can Reduce Bleeding in PAI-1-deficient Patients
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 13 Issue: 2 Year: 2013 Page: 144-150
Author(s): Jerzy Jankun, Ewa Skrzypczak-Jankun